Halozyme Therapeutics, Inc. Forecast and Target Price logo

Halozyme Therapeutics, Inc. Forecast and Target Price

$46.96

Halozyme Therapeutics, Inc. (HALO) Share Price Forecast

Currently 17 wall-street analysts regularly analyze the financials of Halozyme Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Halozyme Therapeutics, Inc. (HALO) have a share price target of $64. This median of share price forecast represents a 36.29% upside from the latest price of $46.96 as on 21.12.24.

Halozyme Therapeutics, Inc. (HALO) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Halozyme Therapeutics, Inc. (HALO) share price will touch around $64 in next 12-months.

Halozyme Therapeutics, Inc. (HALO) Share Price Forecast v/s Share Price Today

Below is a chart showing the percentage difference between Halozyme Therapeutics, Inc.'s share price and its median forecast price. As on 21.12.24, the difference is -8.48%

Halozyme Therapeutics, Inc. (HALO): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms

Halozyme Therapeutics, Inc. (HALO) Share Price : Analyst Recommendation

Based on 17 analysts tracking and researching Halozyme Therapeutics, Inc. (HALO) share have buy recommendation on an average.
3M Ago1M AgoCurrent
Buy
11
12
12
Outperform
2
2
2
Hold
3
3
3
Underperform
1
0
0
Sell
0
0
0

Halozyme Therapeutics, Inc. (HALO) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price